Compliance Rate
Compliance Rate
0%
Compliant submissions
0
Incompliant submissions
0
Total trials
0
My Organizations' Clinical Trials
Showing 4 of 4 entries
View as:
Phase: N/A
Priority: Normal
Start: 07/08/20
End: 08/01/32
Due: 08/01/33
Phase: N/A
Priority: Normal
Start: 03/01/22
End: 03/01/29
Due: 03/01/30
Phase: N/A
Priority: Normal
Start: 12/01/23
End: 10/01/36
Due: 10/01/37
Phase: N/A
Priority: Normal
Start: 05/31/15
End: 06/30/18
Due: 06/30/19
| Title | NCT ID | Organization | User | Status | Start Date | End Date | Reporting Due Date | Last Checked | User Role | Org Created |
|---|---|---|---|---|---|---|---|---|---|---|
| Discontinuation of Antithrombotic Treatment Following Patent Foramen Ovale Closure in Young Patients With Cryptogenic Stroke | NCT04475510 | Josep Rodes-Cabau | user2@example.com | None | 2020-07-08 | 2032-08-01 | 2033-08-01 | - | - | 2025-07-14 |
| Frailty in Patient Undergoing Percutaneous Left Atrial Appendage Closure. | NCT05257954 | Josep Rodes-Cabau | user2@example.com | None | 2022-03-01 | 2029-03-01 | 2030-03-01 | - | - | 2025-07-14 |
| Medical Treatment With or Without Transcatheter Patent Foramen Ovale Closure | NCT05907694 | Josep Rodes-Cabau | user2@example.com | None | 2023-12-01 | 2036-10-01 | 2037-10-01 | - | - | 2025-07-14 |
| Percutaneous Coronary Intervention With the Angiolite Drug-eluting Stent: an Optical Cohenrece Tomography Study | NCT02776267 | Josep Rodes-Cabau | user2@example.com | None | 2015-05-31 | 2018-06-30 | 2019-06-30 | - | - | 2025-07-14 |